Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the EPO notified the Company of its intention to grant a patent application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback